Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 10321-10330 of 13454

Page
per page
  1. CDK9 inhibitor 2
    A3295 CDK9 inhibitor 2
    Summary: CDK9 inhibitor
      ≥42.8 mg/mL
  2. Elacridar hydrochloride
    A3385 Elacridar hydrochloride
    Summary: BCRP and P-GP inhibitor
      Soluble in DMSO
  3. Monomethyl auristatin E
    A3631 Monomethyl auristatin E
    Summary: A type of antimitotic agent that can also be widely used as a cytotoxic component for the preparation of antibody-drug conjugates (ADCs) for cancer research.
      ≥35.9 mg/mL
  4. MRT67307 HCl
    A3635 MRT67307 HCl
    Target: TBK1|MARK1|NUAK1
    Summary: SIK/TBK-1/IKKe inhibitor
      ≥23.25 mg/mL
  5. Paricalcitol
    A3702 Paricalcitol
    Summary: Analog of VD2 active form
      ≥50.7 mg/mL
  6. R1530
    A3746 R1530
    Summary: Antiangiogenesis,mitosis-angiogenesis inhibitor (MAI)
      Soluble in DMSO
  7. SCH772984
    A3805 SCH772984
     19 Citation
    Summary: ERK1 and ERK2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.7 mg/mL
  8. Simeprevir
    A3820 Simeprevir
     1 Citation
    Target: HCV Proteases
    Summary: Inhibitor of HCV NS3/4A protease
      insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
  9. MC-Val-Cit-PAB
    BA2366 MC-Val-Cit-PAB
    Summary: MC-Val-Cit-PAB is a synthesized intermediate and is a toxin-Linker coupling (Drug-Linker Conjugates for ADC).
  10. Palmitoyl carnitine-d3 HCl
    SL1010 Palmitoyl carnitine-d3 HCl
    Summary: A stable isotope deuterated compound of Palmitoyl carnitine

Items 10321-10330 of 13454

Page
per page